Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu • (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats include: biochemistry; cell, developmental and integrated biology; microbiology; molecular genetics; neurobiology; pathology; pharmacology and tocixology; Alabama Drug Discovery Alliance; Bill L. Harbert Institute for Innovation and Entrepreneurship.
“A major issue facing biomedical research,” says Fran Lund, chair of UAB microbiology.
Validated biomarkers are crucial to developing effective treatments for this degenerative disease.
UAB researchers will enroll patients for prospective studies on pathogenesis of a potentially fatal blood clot disorder with a $2.5 million NIH grant.
Wrong shipment of mice led to estrogen breakthrough in trauma survival.
UAB's strengths in clinical care and research are powering an interdisciplinary expedition into largely uncharted territory: neuroinflammatory mechanisms in Parkinson's disease.
E. coli ClpB is a bacterial enzyme that untangles proteins. Such tangles are hallmarks of neurodegenerative diseases like Parkinson’s and Alzheimer’s. A study led by UAB's Aaron Lucius, Ph.D., offers new insight on this amazing molecular machine, and could eventually point toward new treatment approaches.
UAB researchers discover a new protein interaction from the 1918 flu strain that may help influenza circumvent the host immune response that would fight viral infection.
Famed neuroscientist Roger Nicoll, Ph.D., recently came to UAB to explain how he prevailed over great challenges in his life. Grad students in UAB’s Neuroscience Roadmap Scholars Program appreciated that, because they face challenges too. Learn about Nicoll’s tear-inducing speech, and the groundbreaking Roadmap program for underrepresented students, in The Mix.
An Arizona drug company will patent the small peptide drug.
Until now, no toxin had been found in 132 years of study for the deadly pathogen Mycobacterium tuberculosis, which infects 9 million people a year and kills more than 1 million. The novel toxin induces necrotic cell death of macrophages to help the tuberculosis pathogen escape and spread to other cells.